This topic contains a solution. Click here to go to the answer

Author Question: The nurse is asked to speak about weight loss drugs to a group of bariatric clients. What would they ... (Read 105 times)

nmorano1

  • Hero Member
  • *****
  • Posts: 598
The nurse is asked to speak about weight loss drugs to a group of bariatric clients. What would they be told about phentermine, an FDA-approved drug for weight loss?
 
  A) It works by making the body think it is full.
  B) It is approved for approximately 6 months of use.
  C) Tolerance may develop after only a few weeks.
  D) It is a peripheral nervous system drug.

Question 2

The nurse is asked to provide education to an obese client diagnosed with nonalcoholic fatty liver disease. After a discussion of possible causes, the nurse recommends:
 
  1. A modified diet for slow weight loss. 2. Bariatric surgery. 3. A rapid weight loss program. 4. A low-fiber diet.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Liamb2179

  • Sr. Member
  • ****
  • Posts: 365
Answer to Question 1

C
Feedback:
The FDA has approved several appetite suppressants; phentermine is one. Tolerance may develop after only a few weeks, and there is a risk of abuse.

Answer to Question 2

1
Rationale: In an overweight or obese client with fatty liver disease, slow weight loss should be recommended. Rapid weight loss through excessive dieting or bypass surgery should be avoided since it contributes to fatty liver disease. A high-fiber diet is recommended for weight loss and bowel health.




nmorano1

  • Member
  • Posts: 598
Reply 2 on: Aug 2, 2018
Great answer, keep it coming :)


tandmlomax84

  • Member
  • Posts: 323
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

For a complete list of videos, visit our video library